Amphastar Pharmaceuticals(AMPH) - 2025 Q4 - Earnings Call Presentation
Amphastar PharmaceuticalsAmphastar Pharmaceuticals(US:AMPH)2026-02-26 22:00
Financials
Transcript

Corporate Presentation February 2026 Highly Purified Peptide/Protein Biosimilar Interchangeable Proprietary Injectables Inhalation Intranasal New Molecular Peptides Oncology Ophthalmology Rheumatology Forward Looking Statements This presentation and the accompanying oral presentation contain forward-looking statements, of Amphastar Pharmaceuticals, Inc. ("Amphastar", "we". "our" and that are based on our management's current expectations and assumptions and on information currently available to management. ...